Barclays Forecasts Strong Price Appreciation for Clorox (NYSE:CLX) Stock

Clorox (NYSE:CLX) had its price target hoisted by stock analysts at Barclays from $85.00 to $86.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an “underweight” rating on the stock. Barclays‘s target price would indicate a potential downside of 10.15% from the company’s previous close.

CLX has been the subject of a number of other reports. UBS Group lifted their price target on shares of Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a research report on Thursday, July 16th. BNP Paribas Exane decreased their price objective on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a report on Monday. Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. TD Cowen increased their price objective on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Finally, Morgan Stanley dropped their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Reduce” and an average price target of $103.60.

Clorox Trading Up 0.0%

Shares of Clorox stock opened at $95.72 on Tuesday. The stock has a 50 day moving average of $94.94 and a 200 day moving average of $103.94. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The firm has a market capitalization of $11.57 billion, a price-to-earnings ratio of 15.54 and a beta of 0.54. Clorox has a fifty-two week low of $84.70 and a fifty-two week high of $132.03.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts predict that Clorox will post 5.52 earnings per share for the current year.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.63% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in CLX. Wilkins Investment Counsel Inc. grew its position in Clorox by 250.6% in the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after buying an additional 39,360 shares during the last quarter. Morningstar Investment Management LLC boosted its holdings in Clorox by 131.8% in the 4th quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock valued at $6,297,000 after purchasing an additional 35,506 shares in the last quarter. National Pension Service boosted its holdings in Clorox by 68.9% in the 4th quarter. National Pension Service now owns 27,537 shares of the company’s stock valued at $2,777,000 after purchasing an additional 11,233 shares in the last quarter. Birch Hill Investment Advisors LLC acquired a new position in Clorox during the 4th quarter worth approximately $22,103,000. Finally, Ilmarinen Mutual Pension Insurance Co purchased a new position in shares of Clorox during the 4th quarter worth approximately $1,966,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.